본문 바로가기
KERD
논문KCI 등재

듀시엔형 근이영양증과 베커 근이영양증 환자의 심장 기능 평가

Cardiac Assessment in Duchenne and Becker Muscular Dystrophies

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류신경과학

초록

Background: Cardiac problems are common and are a major cause of death in both Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). Early diagnosis and proper management are very important for prolonging life expectancy, improving mobility and the quality of life in dystrophinopathic patients. The object of this study was to assess the cardiac dysfunction in dystrophinopathic patients. Methods: We reviewed the clinical and laboratory findings of 53 male patients with DMD/BMD. The diagnosis was based on clinical criteria suggested by the European neuromuscular center, dystrophin gene analysis and immunohistochemistry of dystrophinopathic patients. We investigated 12-lead electrocardiography (EKG) findings, cardiac echocardiography findings and exon deletion analysis of dystrophin by multiplex polymerase chain reaction. Results: The mean age of 53 patients was 20.98±7.85 years old. On EKG findings of DMD/BMD patients, 50 patients (94.3%) revealed abnormal findings (DMD 36 [94.7%]/BMD 14 [93.3%]). Of the forty nine patients investigated by cardiac echocardiography, 25 patients (51.1%) showed abnormal echocardiographic findings (DMD 18 [51.4%]/BMD 7 [50.0%]), 18 patients (36.7%) had dilated cardiomyopathy, and 7 (14.3%) patients had cardiac symptoms (DMD 4 [11.4%] /BMD 3 [21.4%] numbers). There was no difference in the neurological disability score between normal echocardiographic finding patients and abnormal patients. On DNA analysis by multiplex PCR, the proximal exon deletion of dystrophin genes (exon 1-30) has a significant association with cardiac involvement compared to those of distal exon deletion (exon 31-60) (p=0.034). Conclusions: Because DMD/BMD patients mostly have affected cardiac dysfunctions without clinical symptoms, early diagnosis and appropriate management of asymptomatic cardiac dysfunctions is very important. J Korean Neurol Assoc 25(4):515-520, 2007

Abstract

Background: Cardiac problems are common and are a major cause of death in both Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). Early diagnosis and proper management are very important for prolonging life expectancy, improving mobility and the quality of life in dystrophinopathic patients. The object of this study was to assess the cardiac dysfunction in dystrophinopathic patients. Methods: We reviewed the clinical and laboratory findings of 53 male patients with DMD/BMD. The diagnosis was based on clinical criteria suggested by the European neuromuscular center, dystrophin gene analysis and immunohistochemistry of dystrophinopathic patients. We investigated 12-lead electrocardiography (EKG) findings, cardiac echocardiography findings and exon deletion analysis of dystrophin by multiplex polymerase chain reaction. Results: The mean age of 53 patients was 20.98±7.85 years old. On EKG findings of DMD/BMD patients, 50 patients (94.3%) revealed abnormal findings (DMD 36 [94.7%]/BMD 14 [93.3%]). Of the forty nine patients investigated by cardiac echocardiography, 25 patients (51.1%) showed abnormal echocardiographic findings (DMD 18 [51.4%]/BMD 7 [50.0%]), 18 patients (36.7%) had dilated cardiomyopathy, and 7 (14.3%) patients had cardiac symptoms (DMD 4 [11.4%] /BMD 3 [21.4%] numbers). There was no difference in the neurological disability score between normal echocardiographic finding patients and abnormal patients. On DNA analysis by multiplex PCR, the proximal exon deletion of dystrophin genes (exon 1-30) has a significant association with cardiac involvement compared to those of distal exon deletion (exon 31-60) (p=0.034). Conclusions: Because DMD/BMD patients mostly have affected cardiac dysfunctions without clinical symptoms, early diagnosis and appropriate management of asymptomatic cardiac dysfunctions is very important. J Korean Neurol Assoc 25(4):515-520, 2007

참고문헌 (27)

  1. "107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands", 13, pp.166~172 (2003)
  2. "Dystrophies and heart disease", 12, pp.329~343 (1997)
  3. "Bain RJ. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 1990", pp.271~277
  4. "Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophy", 36, pp.1953~1958 (2000)
  5. "Evaluation of dysrhythmia in children with muscular dystroph", 51, pp.925~931 (2000)
  6. "Duchenne and Becker Muscular Dystrophies", pp.1~4 (1997), London: Royal Society of Medicine Press
  7. "Quantitating severity of neuropathy", pp.686~697 (1993), Philadelphia: WB Saunders
  8. "Benatar A. Subclinical cardiomyopathy in Becker muscular dystrophy. Br Heart J 1992", pp.304~308
  9. "Caskey CT. Multiplex PCR for the diagnosis of Duchenne muscular dystrophy. In a guide to methods and applications. 1st ed. New York", pp.272~281, Academic Press. 1990
  10. "Kunkel LM. Detection of 98% of DMD", BMD gene deletions by polymerase chain reaction. Hum Genet 1990, 45~48
  11. "Kunkel LM. Improved diagnosis of Duchenne", Becker muscular dystrophy. J Clin Invest 1990, 613~619
  12. "The heart in human dystrophinopathies", 99, pp.1~19 (2003)
  13. "Jay CA. Cardiac manifestations and their management in Becker's muscular dystrophy. Am Heart J 1994"
  14. "Cardiac dysfunction with Becker muscular dystrophy", 132, pp.642~647 (1996)
  15. "Nylander E. The heart in Duchenne muscular dystrophy", pp.1239~1244
  16. "Echocardiographic and electrocardiographic findings of cardiomyopathy in Duchenne and Becker-Kiener muscular dystrophies", 26, pp.66~72 (2005)
  17. "et al. Dilating cardiomyopathy as the expression of Xp21 Becker type muscular dystrophy. J Neurol Sci 1992", restag(g), pp.218~221
  18. "Cardiovascular considerations in the management of neuromuscular disease", 15, pp.93~108 (1995)
  19. "Felner JM. Sequence of cardiac changes in Duchenne muscular dystrophy. Am Heart J 1978", pp.283~294
  20. "Becker muscular dystrophy presenting with complete heart block in the sixth decade", 242, pp.398~400 (1995)
  21. "Sugita H. A case of Becker muscular dystrophy presenting cardiac failure as an initial symptom. Rinsho Shinkeigaku 1990", su(hara n), pp.210~213
  22. "et al. Prevalent cardiac involvement in dystrophin Becker type mutation. Neuromuscul Disord 1994", pp.381~386
  23. "Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy", 112, pp.2756~2758 (2005)
  24. "Comi LI. Mutation of dystrophin gene and cardiomyopathy. Neuromuscul Disord 1994", pp.371~379
  25. "Fenwick R. An intact cysteine-rich domain is required for dystrophin function. J Clin Invest 1992", pp.666~672
  26. "Fenwick R. Is the carboxyl-terminus of dystrophin required for membrane association? A novel severe case of Duchenne muscular dystrophy. Ann Neurol 1991", pp.605~610
  27. "et al. Dystrophin in frameshift deletion patients with Becker muscular dystrophy. Am J Hum Genet 1992", pp.562~570

관련 논문AI추천

이 간행물의 다른 논문 (20건)